GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Maravai LifeSciences Holdings Inc (FRA:MAR) » Definitions » 6-1 Month Momentum %

Maravai LifeSciences Holdings (FRA:MAR) 6-1 Month Momentum % : -62.61% (As of Apr. 11, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Maravai LifeSciences Holdings 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2025-04-11), Maravai LifeSciences Holdings's 6-1 Month Momentum % is -62.61%.

The industry rank for Maravai LifeSciences Holdings's 6-1 Month Momentum % or its related term are showing as below:

FRA:MAR's 6-1 Month Momentum % is ranked worse than
90.96% of 1472 companies
in the Biotechnology industry
Industry Median: -13.235 vs FRA:MAR: -62.61

Competitive Comparison of Maravai LifeSciences Holdings's 6-1 Month Momentum %

For the Biotechnology subindustry, Maravai LifeSciences Holdings's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Maravai LifeSciences Holdings's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Maravai LifeSciences Holdings's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Maravai LifeSciences Holdings's 6-1 Month Momentum % falls into.


;
;

Maravai LifeSciences Holdings  (FRA:MAR) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Maravai LifeSciences Holdings  (FRA:MAR) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Maravai LifeSciences Holdings 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Maravai LifeSciences Holdings's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Maravai LifeSciences Holdings Business Description

Traded in Other Exchanges
Address
10770 Wateridge Circle, Suite 200, San Diego, CA, USA, 92121
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.